P
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Recent Filings
- SC 13D/A33.3 KBPOINT Biopharma Global Inc.Dec 27, 5:02 PM ET·0001104659-23-129754
- 8-K277.9 KBPOINT Biopharma Global Inc.Dec 27, 8:54 AM ET·0001193125-23-303512
- SC 13D/A277.0 KBPOINT Biopharma Global Inc.Dec 20, 4:38 PM ET·0000921895-23-002787
- 10-Q6.8 MBPOINT Biopharma Global Inc.Nov 13, 7:15 AM ET·0001811764-23-000046
- SC 13D317.8 KBPOINT Biopharma Global Inc.Nov 6, 1:47 PM ET·0000921895-23-002462
- SC 13D/A39.2 KBPOINT Biopharma Global Inc.Oct 3, 2:57 PM ET·0001104659-23-106344
- 8-K1.3 MBPOINT Biopharma Global Inc.Oct 3, 7:35 AM ET·0001104659-23-106146
- 10-Q10.7 MBPOINT Biopharma Global Inc.Aug 14, 7:30 AM ET·0001811764-23-000038
- 8-K260.5 KBPOINT Biopharma Global Inc.Aug 14, 7:21 AM ET·0001811764-23-000036
- 8-K270.6 KBPOINT Biopharma Global Inc.Aug 3, 4:05 PM ET·0001811764-23-000031
Insiders
10- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
- BVF GP HOLDINGS LLC10% Owner
- BVF I GP LLCSee Explanation of Responses
- BVF II GP LLCSee Explanation of Responses
- BVF INC/IL10% Owner
- BVF PARTNERS L P/IL10% Owner
- BVF Partners OS Ltd.See Explanation of Responses
- DEMERS WILLIAM L.Chief Financial Officer
- FLESHNER NEIL E.Director, Chief Medical Officer
Tickers
No tickers on record
Addresses
business
4850 WEST 78TH STREET
INDIANAPOLIS, IN, 46268
mailing
4850 WEST 78TH STREET
INDIANAPOLIS, IN, 46268
Former Names
- Therapeutics Acquisition Corp.2021-06-30